These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9445761)

  • 1. Observational analysis of German injecting drug users (IDU): survival with and without methadone maintenance treatment. German AIDS Study Group GASG/IdkF.
    Eur J Med Res; 1996 Jan; 1(4):209-14. PubMed ID: 9445761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality of HIV infected clients treated with methadone maintenance treatment in Yili Kazakh autonomous prefecture].
    Liu EW; Wang SJ; Liu Y; Liu W; Chen ZS; Li XY; A LY; Wu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Nov; 45(11):979-84. PubMed ID: 22336271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
    J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone maintenance treatment of heroin abuse in China.
    Lu L; Zhao D; Bao YP; Shi J
    Am J Drug Alcohol Abuse; 2008; 34(2):127-31. PubMed ID: 18293229
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
    Avants SK; Margolin A; Usubiaga MH; Doebrick C
    J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric estimation of survival function of HIV+ patients with doubly censored data.
    Grover G; Shakeri N
    J Commun Dis; 2007 Mar; 39(1):7-12. PubMed ID: 18338710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection.
    Quang-Cantagrel ND; Wallace MS; Ashar N; Mathews C
    Eur J Pain; 2001; 5(4):415-20. PubMed ID: 11743707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
    Antela A; Casado JL; González MJ; Pérez P; Pérez-Elías MJ; Montilla P; Buzón L
    AIDS; 1997 Sep; 11(11):1405-6. PubMed ID: 9302458
    [No Abstract]   [Full Text] [Related]  

  • 19. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
    Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
    Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.